Miyu Kano

机构：National Cancer Institute, Center for Cancer Research · ORCID：0009-0003-1048-2824

发表论文 30 篇 · 总被引 368 次 · h-index 7

代表论文

• BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance (2018 · Science Advances · 被引 147)
• Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma (2020 · Journal of Dermatological Science · 被引 44)
• Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells (2021 · Scientific Reports · 被引 38)
• Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease (2017 · American Journal Of Pathology · 被引 29)
• Anti‐transcriptional intermediary factor 1‐γ antibody as a biomarker in patients with dermatomyositis (2019 · The Journal of Dermatology · 被引 28)
• Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease (2019 · The Journal of Dermatology · 被引 28)